Exercise during treatment for soft tissue sarcoma in an arm or leg
Part of Cancer clinical trials.
This trial studies whether adding an exercise program helps people with soft tissue sarcoma in an arm or leg during a planned treatment course. The treatment they look at is radiation before surgery, then surgery to remove the tumor, and they want to see how exercise affects outcomes and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old
- You have soft tissue sarcoma that was confirmed by a pathology (tissue) report
- The sarcoma is in an arm or a leg (upper or lower extremity)
- Your treatment plan includes radiation before surgery (neo-adjuvant radiation), followed by tumor surgery
- Your surgeon expects to close the wound primarily at the time of surgery (not leaving it open for later closure)
- You can attend follow-up visits and you can personally consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an individualized “prehab” program (exercises and preparation before treatment) to improve recovery and surgical outcomes for adults with deep soft tissue sarcoma in the leg. It’s meant to help your body be as ready as possible for radiotherapy and surgery.
This trial tests combining anlotinib (a targeted therapy), doxorubicin (chemotherapy), and radiation given before surgery to shrink high-grade soft tissue sarcomas. The goal is to make the tumor easier to remove and improve outcomes.
This trial tests a shorter course of radiation (just 5 days) before surgery for soft tissue sarcoma. The goal is to see if a brief, high-dose radiation schedule works as well as or better than the usual longer course—and may be more convenient for you.
This trial tests a step-by-step (sequential) chemotherapy plan given before surgery for adults with specific types of soft tissue sarcoma. The goal is to shrink or control the tumor before the operation and see how well this approach works and is tolerated.
This trial tests a combination of immunotherapy (atezolizumab), chemotherapy (doxorubicin), and radiation before and after surgery for people with high-risk soft tissue sarcoma in the arm, leg, or trunk. The goal is to see if this approach can improve outcomes.
This trial tests giving chemotherapy and radiation therapy together before surgery for soft tissue sarcoma in the arms or legs. The goal is to see if this approach can improve outcomes for people with larger, high-grade, or deep tumors.
Hear when a new Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.